《滬深兩市》上證深成半日跌0.2%-0.5% 煤電股弱 CRO概念股逆市揚
內地昨日(25日)新增本土病例4例,上海市佔3例。上海市文旅局表示,暫停跨省團隊旅遊及「機票+酒店」業務。人行今日(26日)開展1,000億元人民幣(下同)逆回購操作,單日淨投放零500億元。人民幣兌美元中間價上調44點。上證深成低開低走。
上證半日跌18點或0.5%,收報3,566點;深成指跌30點或0.2%,收報14,797點;滬深300指數跌31點或0.6%,報4,865點;創業板指數升不足1點,收報3,475點,成交1,983億元。上證深成半日成交分別爲2,732億元及4,330億元。
中資金融股偏弱,工行(601398.SH)、建行(601939.SH)分別跌0.2%及0.5%。
電力、煤炭股走弱,華能(600011.SH)、華電(600027.SH)、上海電力(600021.SH)跌1.5%-3.3%。中煤(601898.SH)、兗煤(600188.SH)、山西焦煤(000983.SZ)、山西焦化(600740.SH)跌1.6%-6.2%。
憂慮上海疫情爆發,旅遊股下跌,衆信旅遊(002707.SZ)、中青旅(600138.SH)、峨嵋山A(000888.SZ)、凱撒旅遊(000796.SZ)跌1.8%-2.7%。
第六批全國藥品集採採購今起開標,CRO概念股逆市上升,九洲藥業(603456.SH)、藥明康德(603259.SH)、博騰股份(300363.SZ)升4.1%及6.2%。
鋰電池概念股表現偏好,億緯鋰能(300014.SH)、贛鋒鋰業(002460.SZ)、天齊鋰業(002466.SZ)升1.3%-3.8%。寧德時代(300750.SZ)升1%。
半導體股顯着回吐,富瀚微(300613.SZ)、敏芯股份(688286.SH)、卓勝微(300782.SZ)跌4.4%-9.8%。
紫光股份(000938.SZ)間接控股子公司新華三半導體被美國列入相關實體清單,股價低開後靠穩升1.4%。(ta/k) ~
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.